Literature DB >> 26088442

Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR).

Björn Zethelius1,2, Soffia Gudbjörnsdottir3, Björn Eliasson3, Katarina Eeg-Olofsson3, Ann-Marie Svensson3, Jan Cederholm4.   

Abstract

AIMS/HYPOTHESIS: Atrial fibrillation (AF) is more frequent in patients with diabetes than in the general population. However, characteristics contributing to AF risk in diabetes remain speculative.
METHODS: Observational study of 83,162 patients with type 2 diabetes, aged 30-79 years, with no baseline AF, 17% had history of cardiovascular disease (CVD) and 3.3% history of congestive heart failure (CHF), followed up for development of AF during mean 6.8 years from 2005-2007 to 2012. A subgroup of 67,780 patients without history of CVD or CHF was also analysed.
RESULTS: Using Cox regression, cardiovascular risk factors associated with risk for AF were updated mean BMI (HR 1.31 per 5 kg/m(2)) or obesity (HR 1.51), updated mean systolic BP (SBP; HR 1.13 per 10 mmHg) or hypertension (HR 1.71), and cumulative microalbuminuria (HR 1.21), p < 0.001 for all analyses. Male sex, increasing age and height were also significant predictors. HRs were 1.76 for a history of CHF and 2.56 for in-study CHF, while 1.32 for history of CVD and 1.38 for in-study CHD (p < 0.001). Among patients without history of CVD or CHF, significant predictors were similarly BMI, SBP, and cumulative microalbuminuria and CHF. The risk of AF differed in the subgroups achieving or not achieving a target BP < 140/85 mmHg. The HRs for AF were (per 10 mmHg increase) 0.88 and 1.24, respectively. CONCLUSIONS/
INTERPRETATION: The modifiable risk factors high BP, high BMI and albuminuria were strongly associated with AF in type 2 diabetes. CVD, advancing age and height were also associated with AF in type 2 diabetes.

Entities:  

Keywords:  Atrial fibrillation; Cardiovascular diseases; Diabetes mellitus; Myocardial infarction; Registry

Mesh:

Year:  2015        PMID: 26088442     DOI: 10.1007/s00125-015-3666-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers.

Authors:  J Merlo; U Lindblad; H Pessah-Rasmussen; B Hedblad; J Rastam; S O Isacsson; L Janzon; L Råstam
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

2.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Authors:  Lars Frost; Lone Juul Hune; Peter Vestergaard
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

3.  Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II).

Authors:  Jan Cederholm; Soffia Gudbjörnsdottir; Björn Eliasson; Björn Zethelius; Katarina Eeg-Olofsson; Peter M Nilsson
Journal:  J Hypertens       Date:  2012-10       Impact factor: 4.844

4.  The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.

Authors:  M Lind; M Olsson; A Rosengren; A-M Svensson; I Bounias; S Gudbjörnsdottir
Journal:  Diabetologia       Date:  2012-08-16       Impact factor: 10.122

5.  Diabetes mellitus, glycemic control, and risk of atrial fibrillation.

Authors:  Sascha Dublin; Nicole L Glazer; Nicholas L Smith; Bruce M Psaty; Thomas Lumley; Kerri L Wiggins; Richard L Page; Susan R Heckbert
Journal:  J Gen Intern Med       Date:  2010-04-20       Impact factor: 5.128

6.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

7.  LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.

Authors:  B Eliasson; S Gudbjörnsdottir; B Zethelius; K Eeg-Olofsson; J Cederholm
Journal:  Eur J Prev Cardiol       Date:  2013-06-17       Impact factor: 7.804

8.  Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.

Authors:  C J Ostgren; J Merlo; L Råstam; U Lindblad
Journal:  Diabetes Obes Metab       Date:  2004-09       Impact factor: 6.577

9.  Coronary ischemic events after first atrial fibrillation: risk and survival.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; James B Seward; Toshiji Iwasaka; Teresa S M Tsang
Journal:  Am J Med       Date:  2007-04       Impact factor: 4.965

10.  Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study).

Authors:  Jens Friberg; Henrik Scharling; Niels Gadsbøll; Thomas Truelsen; Gorm B Jensen
Journal:  Am J Cardiol       Date:  2004-10-01       Impact factor: 2.778

View more
  12 in total

1.  Electrical atrial vulnerability and renal complications in type 2 diabetes.

Authors:  David Montaigne; Augustin Coisne; Philippe Sosner; Dominique Lacroix; Samy Hadjadj
Journal:  Diabetologia       Date:  2015-12-24       Impact factor: 10.122

2.  Electrical atrial vulnerability and renal complications in type 2 diabetes. Reply to Montaigne D, Coisne A, Sosner P et al [letter].

Authors:  Björn Zethelius; Soffia Gudbjörnsdottir; Björn Eliasson; Katarina Eeg-Olofsson; Ann-Marie Svensson; Jan Cederholm
Journal:  Diabetologia       Date:  2016-02-03       Impact factor: 10.122

3.  Factors associated with atrial fibrillation in Japanese patients with type 2 diabetes mellitus: a cross-sectional study.

Authors:  Natsuki Honda; Akinobu Ochi; Sadahiko Uchimoto; Yoshinori Kakutani; Yuko Yamazaki; Tomoaki Morioka; Tetsuo Shoji; Masaaki Inaba; Masanori Emoto
Journal:  Diabetol Int       Date:  2022-01-24

4.  Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects.

Authors:  Shabbar Jamaly; Lena Carlsson; Markku Peltonen; Peter Jacobson; Lars Sjöström; Kristjan Karason
Journal:  J Am Coll Cardiol       Date:  2016-12-13       Impact factor: 24.094

5.  Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus.

Authors:  Beatriz Moreno; Ana Paula de Faria; Alessandra Mileni Versuti Ritter; Lara Buonalumi Tacito Yugar; Silvia Elaine Ferreira-Melo; Rivadavio Amorim; Rodrigo Modolo; André Fattori; Juan Carlos Yugar-Toledo; Antonio Coca; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-05       Impact factor: 3.738

6.  eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Authors:  Nisha Bansal; Leila R Zelnick; Alvaro Alonso; Emelia J Benjamin; Ian H de Boer; Rajat Deo; Ronit Katz; Bryan Kestenbaum; Jehu Mathew; Cassianne Robinson-Cohen; Mark J Sarnak; Michael G Shlipak; Nona Sotoodehnia; Bessie Young; Susan R Heckbert
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-10       Impact factor: 8.237

7.  Association of Proteinuria and Incident Atrial Fibrillation in Patients With Intact and Reduced Kidney Function.

Authors:  Amber O Molnar; Anan Bader Eddeen; Robin Ducharme; Amit X Garg; Ziv Harel; Megan K McCallum; Jeffrey Perl; Ron Wald; Deborah Zimmerman; Manish M Sood
Journal:  J Am Heart Assoc       Date:  2017-07-06       Impact factor: 5.501

8.  Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Retrospective Cohort.

Authors:  Eulalia Muria-Subirats; Josep Lluis Clua-Espuny; Juan Ballesta-Ors; Blanca Lorman-Carbo; Iñigo Lechuga-Duran; Jose Fernández-Saez; Roger Pla-Farnos
Journal:  Int J Environ Res Public Health       Date:  2020-05-16       Impact factor: 4.614

9.  Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study.

Authors:  Shilan Seyed Ahmadi; Ann-Marie Svensson; Aldina Pivodic; Annika Rosengren; Marcus Lind
Journal:  Cardiovasc Diabetol       Date:  2020-01-18       Impact factor: 9.951

10.  Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.

Authors:  Jakub Gumprecht; Gregory Y H Lip; Adam Sokal; Beata Średniawa; Katarzyna Mitręga; Jakub Stokwiszewski; Łukasz Wierucki; Aleksandra Rajca; Marcin Rutkowski; Tomasz Zdrojewski; Tomasz Grodzicki; Jarosław Kaźmierczak; Grzegorz Opolski; Zbigniew Kalarus
Journal:  Cardiovasc Diabetol       Date:  2021-06-24       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.